Jonathan D. Alpern

Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink

Kayla E. Hanson, Kristin Goddard, Ned Lewis et al. · JAMA Network Open · 2022 · 152 citations · Full text

COVID-19 and Dexamethasone

William M. Stauffer, Jonathan D. Alpern, Patricia F. Walker · JAMA · 2020 · 113 citations

James M. Sanders, Molecular Pharmacology, Marguerite L. Monogue +13

High-Cost Generic Drugs — Implications for Patients and Policymakers

Jonathan D. Alpern, William M. Stauffer, Aaron S. Kesselheim · New England Journal of Medicine · 2014 · 101 citations

Economics, Health Policy, Health Economics +12

Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection

Sara Y. Tartof, Deborah E. Malden, In‐Lu Amy Liu et al. · JAMA Network Open · 2022 · 97 citations · Full text

Off‐Label Therapies for COVID‐19—Are We All In This Together?

Jonathan D. Alpern, Elie Gertner · Clinical Pharmacology & Therapeutics · 2020 · 45 citations · Full text